Ben Khelil, M.; Godet, Y.; Abdeljaoued, S.; Borg, C.; Adotévi, O.; Loyon, R.
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers 2022, 14, 260.
https://doi.org/10.3390/cancers14010260
AMA Style
Ben Khelil M, Godet Y, Abdeljaoued S, Borg C, Adotévi O, Loyon R.
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers. 2022; 14(1):260.
https://doi.org/10.3390/cancers14010260
Chicago/Turabian Style
Ben Khelil, Myriam, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi, and Romain Loyon.
2022. "Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy" Cancers 14, no. 1: 260.
https://doi.org/10.3390/cancers14010260
APA Style
Ben Khelil, M., Godet, Y., Abdeljaoued, S., Borg, C., Adotévi, O., & Loyon, R.
(2022). Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers, 14(1), 260.
https://doi.org/10.3390/cancers14010260